Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yasuhiro Tsuta"'
Autor:
Shuta Ohara, Kenichi Suda, Akira Hamada, Masato Chiba, Masaoki Ito, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Yasuhiro Tsutani
Publikováno v:
Thoracic Cancer, Vol 15, Iss 31, Pp 2229-2234 (2024)
Abstract Background Superior outcomes have been obtained for neoadjuvant treatment with immune checkpoint inhibitors (ICI) plus chemotherapy over neoadjuvant chemotherapy alone, especially in patients with high programmed cell death ligand 1 (PD‐L1
Externí odkaz:
https://doaj.org/article/01fa212b64f949ff8f69a1fbe25e8ccd
Autor:
Rie Shimizu, Kenichi Suda, Toshiki Takemoto, Shota Fukuda, Masato Chiba, Masaki Shimoji, Junichi Soh, Tetsuya Mitsudomi, Yasuhiro Tsutani
Publikováno v:
Surgical Case Reports, Vol 10, Iss 1, Pp 1-5 (2024)
Abstract Background The use of soft coagulation is becoming common in thoracic surgery. Soft coagulation provides rapid hemostasis from small vessels during surgery by dehydrating tissue and denaturing proteins, without burning the tissue. Case prese
Externí odkaz:
https://doaj.org/article/fbb5057d0a6b457fa3cc9b7f19840f04
Autor:
Shota Fukuda, Kenichi Suda, Akira Hamada, Hana Oiki, Shuta Ohara, Masaoki Ito, Junichi Soh, Tetsuya Mitsudomi, Yasuhiro Tsutani
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1412 (2024)
The emergence of acquired resistance to EGFR-tyrosine kinase inhibitors (TKIs) is almost inevitable even after a remarkable clinical response. Secondary mutations such as T790M and C797S are responsible for the resistance to 1st/2nd-generation (1/2G)
Externí odkaz:
https://doaj.org/article/13cb6c41316240a794f6123d8ca258da
Autor:
Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Publikováno v:
Thoracic Cancer, Vol 14, Iss 4, Pp 381-388 (2023)
Abstract Background The S100 calcium‐binding protein A4 (S100A4) and the accumulation of [18F]‐fluoro‐2‐deoxy‐D‐glucose (FDG) in noncancerous interstitial pneumonia (IP) area are predictors of postoperative acute exacerbation (AE) of IP a
Externí odkaz:
https://doaj.org/article/f7bccb167c6c43f68e4fe08ef387262a
Autor:
Atsushi Kagimoto, Yasuhiro Tsutani, Yoshihisa Shimada, Takahiro Mimae, Yoshihiro Miyata, Hiroyuki Ito, Haruhiko Nakayama, Norihiko Ikeda, Morihito Okada
Publikováno v:
Thoracic Cancer, Vol 13, Iss 24, Pp 3477-3485 (2022)
Abstract Background Squamous cell carcinoma of the lung—the second most common subtype of lung cancer—has a poorer prognosis than lung adenocarcinoma. However, in contrast to lobectomy, the oncological outcomes after segmentectomy for primary squ
Externí odkaz:
https://doaj.org/article/d4768ce474d84fdb9d9bfef95ed54d5f
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
For decades, lobectomy has been the recommended surgical procedure for non-small cell lung cancer (NSCLC), including for small-sized lesions. However, two recent pivotal clinical trials conducted by the Japanese Clinical Oncology Group/West Japan Onc
Externí odkaz:
https://doaj.org/article/417750a70eea475999ca3c1f3e1964ff
Autor:
Takahiro Mimae, MD, PhD, Yoshihiro Miyata, MD, PhD, Yasuhiro Tsutani, MD, PhD, Yoshihisa Shimada, MD, PhD, Hiroyuki Ito, MD, PhD, Haruhiko Nakayama, MD, PhD, Norihiko Ikeda, MD, PhD, Morihito Okada, MD, PhD
Publikováno v:
JTCVS Open, Vol 11, Iss , Pp 300-316 (2022)
Objective: Lung adenocarcinoma often includes noninvasive components with postoperative lepidic morphology on pathologic specimens that appear on preoperative high-resolution computed tomography (HRCT) images as ground-glass opacity (GGO). We aimed t
Externí odkaz:
https://doaj.org/article/05d3aebba2d3415db676e9d1be8a1b6b
Autor:
Masaoki Ito, Yoshihiro Miyata, Kei Kushitani, Atsushi Kagimoto, Daisuke Ueda, Yasuhiro Tsutani, Yukio Takeshima, Morihito Okada
Publikováno v:
Thoracic Cancer, Vol 12, Iss 23, Pp 3141-3149 (2021)
Abstract Introduction Tumor size is an absolute recurrence risk in lung cancer. Although morphological features also reflect recurrence risk, its significance among lower‐risk cases characterized by small size is unknown. We aimed to evaluate the r
Externí odkaz:
https://doaj.org/article/661e0f51c8a84c069ea1cc18bd0b1629
Publikováno v:
Biomolecules, Vol 13, Iss 9, p 1377 (2023)
Several clinical trials have been revolutionizing the perioperative treatment of early-stage non-small cell lung cancer (NSCLC). Many of these clinical trials involve cancer immunotherapies with antibody drugs that block the inhibitory immune checkpo
Externí odkaz:
https://doaj.org/article/0444c87989cc455ea42db0fd78dfab72
Autor:
Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Acute exacerbation (AE) of interstitial pneumonia (IP) is the most fatal complication after lung resection for lung cancer. To improve the prognosis of lung cancer with IP, the risk factors of AE of IP after lung resection should
Externí odkaz:
https://doaj.org/article/0ac4c3035c654d2bb1965658e40e21c9